Financials
- Market Capitalization 307.53 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-19.75
ratio cours/chiffre d'affaires
0.6
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3123 | EBS Emergent BioSolutions Inc. Common Stock | 7.83 USD | +4.26% | -4.40% | -5.66% | -26.96% | 404.00 M USD | ||
| 3175 | AKBA Akebia Therapeutics, Inc. - Common Stock | 1.39 USD | -0.71% | 0.00% | +51.09% | +17.80% | 372.88 M USD | ||
| 3386 | TKNO Alpha Teknova, Inc. - Common Stock | 5.42 USD | +0.18% | +3.04% | +31.87% | +23.18% | 290.59 M USD | ||
| 3480 | SIGA SIGA Technologies Inc. - Common Stock | 3.49 USD | +2.05% | -2.24% | -19.40% | -58.94% | 250.32 M USD |